Hollings Annual Report 2023 FINAL - Flipbook - Page 7
EXTERNAL SCIENTIFIC ADVISORY BOARD
Comprised of nationally-recognized leaders in cancer research and treatment, our External Scientific Advisory
Board (ESAB) serves a key role in MUSC Hollings Cancer Center’s planning and evaluation of its research
programs and supporting research infrastructure.
Howard H. Bailey, M.D. — Chair
UW Carbone Cancer Center
Ruben A. Mesa, M.D., FACP
Wake Forest Baptist Comprehensive Cancer Center
Lisa M. Coussens, M.D. (h.c.), Ph.D., FAACR, FAIO
OHSU Knight Cancer Institute
Motomi Mori, Ph.D., MBA
St. Jude Children’s Research Hospital
B. Mark Evers, M.D., FACS
Markey Cancer Center
Julie C. Schaum, MS
Vanderbilt-Ingram Cancer Center
Ernest Hawk, M.D., MPH
MD Anderson Cancer Center
Tom A. Sellers, Ph.D., MPH
OHSU Knight Cancer Institute
Timothy Hla, Ph.D.
Dana-Farber/Harvard Cancer Center
Danny R. Welch, Ph.D.
The University of Kansas Cancer Center
Kimberly F. Kerstann, Ph.D.
Emory Winship Cancer Institute
Eileen White, Ph.D.
Rutgers Cancer Institute of New Jersey
Anita Kinney, Ph.D., RN
Rutgers Cancer Institute of New Jersey
Cheryl Willman, M.D.
Mayo Clinic Comprehensive Cancer Center
Christopher I. Li, M.D., Ph.D.
Fred Hutchinson Cancer Center
Nicholas Shungu, M.D.
Travis Poole, MHA
Chief Administrative Officer
Kevin Roggin, M.D.
Chief, MUSC Surgical Oncology
Division
Steven A. Rosenzweig, Ph.D.
Associate Director, Shared Resources
Associate Director, Office of
Programs to Enhance Diversity
(OPED)
Abi Siva, M.D.
Director of Medical Oncology
Benjamin Toll, Ph.D.
Associate Director, Education &
Training
Laura Sample, MHA, FACHE
Oncology Network Administrator
Celebrating 30 Years
5
